ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

284. Craft AP, Finer N, Barrington KJ. Vancomycin for prophylaxis against sepsis in preterm neonates. CochraneDatabase of Systematic Reviews 2000; Issue 1. Art. No.: CD001971. DOI: 10.1002/14651858. CD001971.285. Norden CW. Application of antibiotic ointment to the site of venous catheterization?a controlled trial. J InfectDis 1969; 120:611?5.286. Zinner SH, Denny-Brown BC, Braun P, Burke JP, Toala P, Kass EH. Risk of infection with intravenousindwelling catheters: effect of application of antibiotic ointment. J Infect Dis 1969; 120:616?9.287. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcusaureus bacteremia. N Engl J Med 2001; 344:11?6.288. Chow JW, Yu VL. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection andapproaches to prophylaxis. Arch Intern Med 1989; 149:1258?62.289. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients onhemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315:91?6.290. Casewell MW. The nose: an underestimated source of Staphylococcus aureus causing wound infection. JHosp Infect 1998; 40:S3?11.291. Hill RL, Fisher AP, Ware RJ, Wilson S, Casewell MW. Mupirocin for the reduction of colonization of internaljugular cannulae?a randomized controlled trial. J Hosp Infect 1990; 15:311?21.292. Sesso R, Barbosa D, Leme IL, et al. Staphylococcus aureus prophylaxis in hemodialysis patients usingcentral venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998; 9:1085?92.293. Boelaert JR, Van Landuyt HW, Godard CA, et al. Nasal mupirocin ointment decreases the incidence ofStaphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 1993; 8:235?9.294. Netto dos Santos KR, de Souza Fonseca L, Gontijo Filho PP. Emergence of high-level mupirocin resistancein methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect ControlHosp Epidemiol 1996; 17:813?6.295. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillinresistantStaphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control HospEpidemiol 1996; 17:811?3.296. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention withpolysporin ointment. J Am Soc Nephrol 2003; 14:169?79.297. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for theprevention of infections associated with intravascular catheters in patients undergoing hemodialysis:systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008; 47:83?93.298. Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter-related bacteraemia with an antimicrobiallock solution: a metaanalysis of prospective randomized trials. Nephrol Dial Transplant 2008; 23:1666?72.299. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter lockingsolutions in the prevention of catheter-related infection. Am J Kidney Dis 2008; 51:233?41.300. Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstreaminfection associated with central venous access devices: a meta-analysis of prospective, randomized trials.Clin Infect Dis 2006; 43:474?84.301. Sanders J, Pithie A, Ganly P, et al. A prospective double-blind randomized trial comparing intraluminalethanol with heparinized saline for the prevention of catheter-associated bloodstream infection inimmunosuppressed haematology patients. J Antimicrob Chemother 2008; 62:809?15.302. Schinabeck MK, Ghannoum MA. Biofilm-related indwelling medical device infections. In: Pace JL, RuppME, Finch RG, eds. Biofilms, infection, and antimicrobial therapy. Boca Raton: Taylor and Francis, 2006:39?50.64